Endoscopy 2022; 54(S 01): S72
DOI: 10.1055/s-0042-1744729
Abstracts | ESGE Days 2022
ESGE Days 2022 Oral presentations
15:30–16:30 Friday, 29 April 2022 Club A. Gastroparesis and outlet obstruction

G-POEM IN REFRACTORY GASTROPARESIS, FOR WHOM? LONG TERM OUTCOMES AND PREDICTIVE SCORE TO IMPROVE PATIENT SELECTION

A. Labonde
1   CHU de Limoges, Limoges, France
,
G. Lades
1   CHU de Limoges, Limoges, France
,
A. Debourdeau
2   CHU de Montpellier, Montpellier, France
,
O. Ragi
3   CHU Lyon, Lyon, France
,
L. Lehmann
4   Polyclinique de Limoges, Limoges, France
,
V. Vitton
5   APHM Hôpital Nord, Marseille, France
,
M. Barthet
5   APHM Hôpital Nord, Marseille, France
,
R. Legros
1   CHU de Limoges, Limoges, France
,
J. Albouys
1   CHU de Limoges, Limoges, France
,
S. Geyl
1   CHU de Limoges, Limoges, France
,
V. Loustaud-Ratti
1   CHU de Limoges, Limoges, France
,
J. Monteil
1   CHU de Limoges, Limoges, France
,
S. Gonzalez
5   APHM Hôpital Nord, Marseille, France
,
J.M. Gonzalez
5   APHM Hôpital Nord, Marseille, France
,
J. Jacques
1   CHU de Limoges, Limoges, France
› Author Affiliations
 

Aims Limited data exist concerning the long-term efficiency of G-POEM as a treatment of refractory gastroparesis. This study evaluates the 3-year results of G-POEM in patients with refractory gastroparesis, then investigated predictive factors for procedure success or failure.

Methods This was a prospective multicenter study of all G-POEM operations performed in two expert French centers for refractory gastroparesis with at least 3 years of follow-up (n=46). GCSI was recorded every 6 months during follow-up.

Results Clinical success was 65.2% at 36 months. Median GCSI decreased from 3.33 to 1.80 (p<0.0001) with improvement in all subscales. We create a predictive score concerning G-POEM success or failure to which points were assigned as follows:

Table 1

Criterion

Score assigned

Nausea subscale<2

+1

Satiety subscale>4

+1

Bloating subscale>3.5

+1

Retention at 4 hours on scintigraphy>50%

+1

A threshold of 2 was identified by receiver operating characteristic curve analysis with an area under the curve of 0.825 that predicted clinical success with 93.3% sensitivity, 56.3% specificity, 80% PPV, 81.8% NPV and 80.4% accuracy. Patients with a score≥2 were significantly more likely to be responders at 3 years than were patients with a score<2 (80% and 18% respectively; p=0.0004).

Conclusions The clinical success of G-POEM for refractory gastroparesis was 65.2% at 36 months. Our predictive score offers an easy tool that should be confirmed in other studies.



Publication History

Article published online:
14 April 2022

© 2022. European Society of Gastrointestinal Endoscopy. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany